We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.98B
AUM Growth
+$132M
Cap. Flow
+$20.2M
Cap. Flow %
0.34%
Top 10 Hldgs %
41.51%
Holding
666
New
23
Increased
324
Reduced
223
Closed
42

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$142M
2
ASML icon
ASML
ASML
+$117M
3
TSEM icon
Tower Semiconductor
TSEM
+$112M
4
LRCX icon
Lam Research
LRCX
+$88M
5
MU icon
Micron Technology
MU
+$53.9M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$81.3M
2
LITE icon
Lumentum
LITE
+$72.3M
3
PM icon
Philip Morris
PM
+$40M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
META icon
Meta Platforms (Facebook)
META
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 54.47%
2 Communication Services 12.44%
3 Consumer Discretionary 11.77%
4 Consumer Staples 6.03%
5 Healthcare 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REXR icon
326
Rexford Industrial Realty
REXR
$8.38B
$117K ﹤0.01%
3,579
-342
-9% -$12.8K
FR icon
327
First Industrial Realty Trust
FR
$9.08B
$116K ﹤0.01%
2,003
-189
-9% -$11.2K
APLS
328
DELISTED
Apellis Pharmaceuticals
APLS
$114K ﹤0.01%
2,841
+356
+14% +$7.67K
RL icon
329
Ralph Lauren
RL
$22.8B
$114K ﹤0.01%
+330
New +$117K
CAI
330
Caris Life Sciences
CAI
$4.45B
$113K ﹤0.01%
6,337
+794
+14% +$17.4K
KKR icon
331
KKR & Co
KKR
$87.2B
$113K ﹤0.01%
+1,218
New +$128K
SRRK icon
332
Scholar Rock
SRRK
$6.1B
$113K ﹤0.01%
2,291
+287
+14% +$12.9K
ARE icon
333
Alexandria Real Estate Equities
ARE
$8.82B
$109K ﹤0.01%
2,353
-228
-9% -$12K
MIRM icon
334
Mirum Pharmaceuticals
MIRM
$7.14B
$107K ﹤0.01%
1,155
+147
+15% +$13.8K
TERN
335
DELISTED
Terns Pharmaceuticals
TERN
$107K ﹤0.01%
2,023
+253
+14% +$10.4K
APGE icon
336
Apogee Therapeutics
APGE
$10.1B
$104K ﹤0.01%
1,232
+155
+14% +$11.3K
ERIC icon
337
Ericsson
ERIC
$31.6B
$104K ﹤0.01%
+9,197
New +$99.6K
ERAS icon
338
Erasca
ERAS
$6.73B
$103K ﹤0.01%
6,372
+798
+14% +$9.43K
CRSP icon
339
CRISPR Therapeutics
CRSP
$4.74B
$102K ﹤0.01%
2,140
+268
+14% +$14.1K
STAG icon
340
STAG Industrial
STAG
$7.99B
$102K ﹤0.01%
2,822
-271
-9% -$10.3K
XENE icon
341
Xenon Pharmaceuticals
XENE
$6.45B
$101K ﹤0.01%
1,735
+218
+14% +$10K
FOLD
342
DELISTED
Amicus Therapeutics
FOLD
$100K ﹤0.01%
6,929
+866
+14% +$12.4K
YUM icon
343
Yum! Brands
YUM
$40.6B
$99K ﹤0.01%
637
– –
IMVT icon
344
Immunovant
IMVT
$8.12B
$97.8K ﹤0.01%
3,936
+493
+14% +$12.8K
TRNO icon
345
Terreno Realty
TRNO
$7.91B
$95.9K ﹤0.01%
1,562
-150
-9% -$9.41K
SSD icon
346
Simpson Manufacturing
SSD
$7.63B
$94.4K ﹤0.01%
+550
New +$101K
TREX icon
347
Trex
TREX
$4.46B
$91K ﹤0.01%
+2,500
New +$101K
EPRT icon
348
Essential Properties Realty Trust
EPRT
$7.19B
$91K ﹤0.01%
2,996
-287
-9% -$9.09K
LGND icon
349
Ligand Pharmaceuticals
LGND
$6.12B
$88.4K ﹤0.01%
443
+57
+15% +$11.3K
SYRE icon
350
Spyre Therapeutics
SYRE
$8.92B
$87.9K ﹤0.01%
1,743
+220
+14% +$8.29K
12 13
14
15 16

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, GF Fund Management held 666 positions worth $5.98B, up 2.3% from $5.85B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

GF Fund Management's Q1 2026 filing shows 23 new, 324 increased, 223 reduced and 42 closed positions. Its largest new stake was Coherent: 98,000 shares worth $23.3M. The largest sale was Sandisk, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 51% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q1 2026 buy was Coherent: 98,000 shares worth $23.3M.
  • GF Fund Management added most to Walmart Inc in Q1 2026, an estimated $142M increase.
  • GF Fund Management's biggest Q1 2026 reduction was Sandisk, cutting an estimated $81.3M.
  • GF Fund Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.4M.
  • GF Fund Management's ten largest holdings make up 42% of its $5.98B portfolio in Q1 2026.
  • GF Fund Management opened 23 new positions and closed 42 in Q1 2026.
  • GF Fund Management's portfolio value rose 2.3% quarter-over-quarter to $5.98B.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.